MediTox s.r.o.


Main activities

Preclinical research and development in the field of cardiovascular disorders, ophthalmic diseases, diabetes, vaccine development

Comprehensive preclinical and toxicological service for human and veterinary pharmaceuticals, biological drugs, medical devices (PHARMA), food additives and chemicals and chemical preparations (REACH)

Animal models of selected human diseases (cardiovascular, ophthalmic, diabetes, ophthalmic, …)

Animal breeding – accredited breeding facility (dogs and non-human primates)
Ref. No.: 38715/2015-MZE-17214

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.


MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.


The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with, flexibility and competitive pricing.



Bio Asia 2017, Feb. 06 – Feb. 08, Hyderabad, India

Bio Asia 2017



BIO-Europe Spring 2017, March 20 - 22, Barcelona, Spain

BIO-Europe Spring 2017



BIO International Convention 2017, June 19 – 22, San Diego, USA

BIO International Convention 2017



Nordic Life Sciences Partnering 2017, September 12 – 14, Malmo, Sweden

Nordic Life Sciences Partnering 2017



CPhI Worldwide 2017, October 24 – 26, Frankfurt, Germany

CPhI Worldwide 2017


MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.